Intersect ENT, Inc.
Records under this name other than the patents Intersect ENT, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,688,289 | Systems and Methods for Sinus Access Formerly held In force · High confidence | In force | High confidence | |
| US 8,337,454 | Device and methods for treating paranasal sinus conditions Formerly held In force Term ended Oct 20, 2026 · From the USPTO record | In force | Term ended Oct 20, 2026 | From the USPTO record |
| US 7,547,323 | Stent for irrigation and delivery of medication Term ended Term ended Aug 29, 2026 · From the USPTO record | Term ended | Term ended Aug 29, 2026 | From the USPTO record |
| US 8,802,131 | Devices and Methods for Delivering Active Agents to the Osteomeatal Complex Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 11,123,091 | Device and methods for treating paranasal sinus conditions Term ended Term ended Apr 30, 2026 · From the USPTO record | Term ended | Term ended Apr 30, 2026 | From the USPTO record |
| US 8,740,839 | Device and methods for treating paranasal sinus conditions Term ended Term ended Apr 4, 2026 · From the USPTO record | Term ended | Term ended Apr 4, 2026 | From the USPTO record |
| US 9,585,681 | Device and methods for treating paranasal sinus conditions Term ended Term ended Apr 4, 2026 · From the USPTO record | Term ended | Term ended Apr 4, 2026 | From the USPTO record |
| US 7,951,132 | Sinus delivery of sustained release therapeutics Term ended Term ended Feb 1, 2025 · From the USPTO record | Term ended | Term ended Feb 1, 2025 | From the USPTO record |
| US 7,951,133 | Sinus delivery of sustained release therapeutics Term ended Term ended Feb 1, 2025 · From the USPTO record | Term ended | Term ended Feb 1, 2025 | From the USPTO record |
| US 11,291,812 | Sinus delivery of sustained release therapeutics Term ended Term ended May 10, 2024 · From the USPTO record | Term ended | Term ended May 10, 2024 | From the USPTO record |